Venture studioJetpack Ventures is a venture studio based in the United States that funds and builds early-stage technology companies. They emphasize a hands-on approach to support innovative and disruptive startups.
Landmark BioVentures AG
Landmark BioVentures AG is a Basel-based biotechnology company-creation and drug-development platform that co-founds and advances a nexus of biotech companies focused on developing first-in-class therapeutics. The organization employs a lean operations model to streamline drug development processes.
- Website
- landmarkbioventures.com
- Founded
- 2021
- Recorded stages
- Pre Seed, Seed
- Focus sectors
- Biotech, Healthcare
- Recorded regions
- European Union
Online destinations
Find Landmark BioVentures AG online
Public destinations are grouped by their documented relationship to the organization. A listed link does not by itself prove ownership or control.
Official links
Destinations the organization presents as part of its public presence.
Overview
Landmark BioVentures AG is a corporate and drug development organization based in Basel, Switzerland. The company was founded with a mission to advance therapies efficiently and responsibly through innovative methods and a focus on lean operations. Landmark BioVentures aims to improve patient outcomes and deliver value to stakeholders by streamlining drug development processes.
Focus
Landmark BioVentures focuses on developing first-in-class therapeutics targeting critical areas such as neoplasm, uncontrolled inflammation, neovascularization, and fibrosis. The organization employs a catalytic model that emphasizes lean operations and smart resource allocation to accelerate drug development and de-risk projects.
Support
Landmark BioVentures offers a hands-on corporate development model, strategic partnerships, and a focus on lean operations to support biotech companies in drug development. The organization emphasizes smart resource allocation to accelerate projects and de-risk therapeutic developments.
Questions
Q: What is the focus of Landmark BioVentures? A: Landmark BioVentures focuses on developing first-in-class therapeutics in areas such as neoplasm, inflammation, neovascularization, and fibrosis.
Q: How does Landmark BioVentures support its portfolio companies? A: The organization employs a catalytic model that emphasizes lean operations and smart resource allocation to accelerate drug development and de-risk projects.
Overlapping documented focus
Similar venture studios
Venture studio
Venture studioSuperSonic is a commercialization studio based in the USA, with additional teams in India and the Philippines. They focus on incubating ideas, building products, and scaling technologies for various industries.
Venture studioeureKARE is an investment company and biotech startup studio based in Luxembourg, focusing on synthetic biology and microbiome innovations. It aims to bridge the gap between academia and industry by developing and commercializing scientific advancements.
Superscout Pro
Build a scout record investors can understand.
- Keep a private deal vault with timestamps
- Write richer memos and evaluations
- Compare investor and program fit
- Manage sources, next actions, and follow-up
$99$249 first year
Superscout ProIllustrative
Scout profile Structured activity
Memo drafted
Submitted
Following
Superscout documents Landmark BioVentures AG independently from canonical records and linked sources. Missing facts stay missing.
Sources and known limits
Last reviewed .
Terms, dates, and eligibility can change. Confirm time-sensitive details with the original source.
Stage and region classifications are shown as recorded. Broad labels such as “Global” and category-like stage labels may still need normalization.
Superscout is not affiliated with, endorsed by, or acting on behalf of the organizations documented here.